Cardiovascular Systems (CSII) Misses Q2 EPS by 10c

Cardiovascular Systems (NASDAQ: CSII) reported Q2 EPS of ($0.23), $0.10 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $59.13 million versus the consensus estimate of $63.17 million.

GUIDANCE:

Cardiovascular Systems sees FY2022 revenue of $235-245 million.

For earnings history and earnings-related data on Cardiovascular Systems (CSII) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
• Evogene (EVGN) Tops Q2 EPS by 15c